ReviewKidney diseases (Basel, Switzerland)2023

Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Nondiabetic Patients with Chronic Kidney Disease: A Review of Recent Evidence.

Junhao Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.